Cefdinir and Sinusitis - a phase IV clinical study of FDA data
Summary:
Sinusitis is reported as a side effect among people who take Cefdinir (cefdinir), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Epinephrine, and have Immunodeficiency common variable.
The phase IV clinical study analyzes which people have Sinusitis when taking Cefdinir. It is created by eHealthMe based on reports of 8,699 people who have side effects when taking Cefdinir from the FDA, and is updated regularly.
What is Cefdinir?
Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,209 Cefdinir users. Check the latest studies of Cefdinir.
What is Sinusitis?
Sinusitis (inflammation of sinus) is found to be associated with 2,391 drugs and 2,688 conditions by eHealthMe. Check the latest studies of Sinusitis.
8,699 people reported to have side effects when taking Cefdinir.
Among them, 502 people (5.77%) have Sinusitis.
Among these 502 people:
How long have people been on Cefdinir when they have Sinusitis? *
What is the gender of people who have Sinusitis when taking Cefdinir? *
What is the age of people who have Sinusitis when taking Cefdinir? *
What are other drugs people take besides Cefdinir? *
What are other side effects people have besides Sinusitis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Cefdinir and have Sinusitis?
- Check whether Sinusitis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cefdinir:
- Cefdinir (9,209 reports)
Sinusitis treatments and more:
- Sinusitis (153,478 reports)
How severe was Sinusitis and when was it recovered:
Expand to all the drugs that have ingredients of cefdinir:
- Sinusitis and drugs with ingredients of cefdinir (438 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Common Cefdinir side effects:
- Cefdinir side effect: Sinusitis (inflammation of sinus) (502 reports)
Browse all side effects of Cefdinir:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon drugs associated with Sinusitis:
- Enbrel side effect: Sinusitis (17,908 reports)
- Prednisone side effect: Sinusitis (17,533 reports)
- Humira side effect: Sinusitis (15,043 reports)
- Methotrexate side effect: Sinusitis (14,571 reports)
- Diphen side effect: Sinusitis (9,389 reports)
- Hydramine side effect: Sinusitis (9,371 reports)
- Acetaminophen side effect: Sinusitis (7,868 reports)
- Pantoprazole side effect: Sinusitis (7,389 reports)
- Xeljanz side effect: Sinusitis (7,347 reports)
- Vitamin d side effect: Sinusitis (7,126 reports)
Browse all the drugs that are associated with Sinusitis:
- Sinusitis (2,391 drugs)
Common conditions associated with Sinusitis:
- Ra: 27,570 reports
- Arthritis - rheumatoid: 27,509 reports
- Asthma: 7,679 reports
- Chronic asthma: 7,650 reports
- Psoriatic arthropathy: 7,176 reports
- Psoriatic arthropathy aggravated: 7,170 reports
- Psoriasis: 6,971 reports
- Ms: 6,617 reports
- Multiple sclerosis: 6,608 reports
- Immunodeficiency common variable: 6,300 reports
Browse all the conditions that are associated with Sinusitis:
- Sinusitis (2,688 conditions)
Drugs similar to Cefdinir and Sinusitis :
How the study uses the data?
The study uses data from the FDA. It is based on cefdinir (the active ingredients of Cefdinir) and Cefdinir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Meclizine cause Glare? - now
- Zofran and Impaired Gastric Emptying for Girls aged 10-19 - a second ago
- Could Formoterol Fumarate cause Delirium? - 14 seconds ago
- Acute Coronary Syndrome and Hoarseness Or Changing Voice - 14 seconds ago
- Could Cisplatin cause Skin Toxicity? - 14 seconds ago
- Drug interactions of Lopurin and Bosulif - 18 seconds ago
- Sam-E vs. Wellbutrin, side effect and effectiveness comparison - 31 seconds ago
- Could Combivent cause Delirium? - 34 seconds ago
- Drug interactions of Spironolactone and Jentadueto - 37 seconds ago
- Vitamin B and Topamax drug interactions for women aged 30-39 - 40 seconds ago